Literature DB >> 17297558

Genistein inhibits the contact-stimulated migration of prostate cancer cells.

Katarzyna Miękus1, Zbigniew Madeja.   

Abstract

The results of several epidemiological studies have suggested that a soybean-based diet is associated with a lower risk of prostate cancer. We investigated the effect of the soy isoflavone genistein on the proliferation and contact-stimulated migration of rat prostatic carcinoma MAT-LyLu and AT-2 cell lines. Genistein almost completely inhibited the growth of both MAT-LyLu and AT-2 cells in the concentration range from 25 to 100 muM, but the addition of 1 muM genistein to the medium significantly stimulated the proliferation of both cell lines. Additionally, at concentrations above 25 muM, genistein showed a potent cytotoxic effect. However, the central finding of this study is that at physiologically relevant concentrations (1 muM and 10 muM), genistein inhibits the motility of prostate cancer cells stimulated by homo-and heterotypic contacts. These results show that at physiological concentrations, genistein exerts an inhibitory effect on the migration of prostate cancer cells and suggest that it may be one of the factors responsible for the anti-metastatic activity of plant isoflavonoids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297558      PMCID: PMC6275706          DOI: 10.2478/s11658-007-0007-0

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  37 in total

1.  Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats.

Authors:  M Pollard; P H Luckert
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

2.  Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.

Authors:  J Wietrzyk; J Boratynski; G Grynkiewicz; A Ryczynski; C Radzikowski; A Opolski
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

3.  Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.

Authors:  Y Liu; E Kyle; R Lieberman; J Crowell; G Kellof; R C Bergan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 4.  The metastatic process: basic research and clinical implications.

Authors:  A F Chambers
Journal:  Oncol Res       Date:  1999       Impact factor: 5.574

5.  Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.

Authors:  Tommaso Simoncini; Camila Scorticati; Paolo Mannella; Ahmed Fadiel; Maria S Giretti; Xiao-Dong Fu; Chiara Baldacci; Silvia Garibaldi; Antonella Caruso; Letizia Fornari; Frederick Naftolin; Andrea R Genazzani
Journal:  Mol Endocrinol       Date:  2006-04-06

6.  Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats.

Authors:  W Pan; K Ikeda; M Takebe; Y Yamori
Journal:  J Nutr       Date:  2001-04       Impact factor: 4.798

7.  Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro.

Authors:  Pamela J Magee; Hugh McGlynn; Ian R Rowland
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

8.  A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.

Authors:  R K Severson; A M Nomura; J S Grove; G N Stemmermann
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

9.  Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.

Authors:  Yiwei Li; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2002-12-05       Impact factor: 8.679

10.  Plasma concentrations of phyto-oestrogens in Japanese men.

Authors:  H Adlercreutz; H Markkanen; S Watanabe
Journal:  Lancet       Date:  1993-11-13       Impact factor: 79.321

View more
  7 in total

Review 1.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 2.  Inhibition of cancer cell invasion and metastasis by genistein.

Authors:  Janet M Pavese; Rebecca L Farmer; Raymond C Bergan
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 3.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

Review 4.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

5.  Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations.

Authors:  Marta Czernik; Jolanta Sroka; Zbigniew Madeja; Jarosław Czyz
Journal:  Cell Mol Biol Lett       Date:  2008-02-21       Impact factor: 5.787

6.  Poly(L-lactide-co-glycolide) thin films can act as autologous cell carriers for skin tissue engineering.

Authors:  Aleksandra Zuber; Julia Borowczyk; Eliza Zimolag; Malgorzata Krok; Zbigniew Madeja; Elzbieta Pamula; Justyna Drukala
Journal:  Cell Mol Biol Lett       Date:  2014-05-13       Impact factor: 5.787

Review 7.  Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.

Authors:  Hardeep Singh Tuli; Muobarak Jaber Tuorkey; Falak Thakral; Katrin Sak; Manoj Kumar; Anil Kumar Sharma; Uttam Sharma; Aklank Jain; Vaishali Aggarwal; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.